DE60213785D1 - Saponin inaktivierte mykoplasma impfstoffe - Google Patents

Saponin inaktivierte mykoplasma impfstoffe

Info

Publication number
DE60213785D1
DE60213785D1 DE60213785T DE60213785T DE60213785D1 DE 60213785 D1 DE60213785 D1 DE 60213785D1 DE 60213785 T DE60213785 T DE 60213785T DE 60213785 T DE60213785 T DE 60213785T DE 60213785 D1 DE60213785 D1 DE 60213785D1
Authority
DE
Germany
Prior art keywords
saponin
vaccines
inactivated
mycoplasmic
mycoplasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60213785T
Other languages
English (en)
Other versions
DE60213785T2 (de
Inventor
Robin Ashley John Nicholas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE60213785D1 publication Critical patent/DE60213785D1/de
Publication of DE60213785T2 publication Critical patent/DE60213785T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60213785T 2001-05-03 2002-05-03 Saponin inaktivierte mykoplasma impfstoffe Expired - Lifetime DE60213785T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0110851.3A GB0110851D0 (en) 2001-05-03 2001-05-03 Vaccine
GB0110851 2001-05-03
PCT/GB2002/002062 WO2002089838A1 (en) 2001-05-03 2002-05-03 Saponin inactivated mycoplasma vaccine

Publications (2)

Publication Number Publication Date
DE60213785D1 true DE60213785D1 (de) 2006-09-21
DE60213785T2 DE60213785T2 (de) 2007-08-23

Family

ID=9913953

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60213785T Expired - Lifetime DE60213785T2 (de) 2001-05-03 2002-05-03 Saponin inaktivierte mykoplasma impfstoffe

Country Status (12)

Country Link
US (1) US20040170652A1 (de)
EP (1) EP1387693B1 (de)
AT (1) ATE335505T1 (de)
CA (1) CA2445997A1 (de)
CY (1) CY1107538T1 (de)
DE (1) DE60213785T2 (de)
DK (1) DK1387693T3 (de)
ES (1) ES2269672T3 (de)
GB (1) GB0110851D0 (de)
MX (1) MXPA03010053A (de)
PT (1) PT1387693E (de)
WO (1) WO2002089838A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US20070009545A1 (en) 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
CN101721694B (zh) * 2009-11-07 2013-01-30 中国农业科学院兰州兽医研究所 山羊支原体肺炎二联灭活疫苗及其制备方法
LT3334454T (lt) 2015-08-14 2022-12-27 Zoetis Services Llc Mycoplasma bovis kompozicijos
CN110551634A (zh) * 2019-09-04 2019-12-10 中国农业科学院兰州兽医研究所 一种山羊支原体山羊肺炎亚种分离培养方法
CN110551653A (zh) * 2019-09-04 2019-12-10 中国农业科学院兰州兽医研究所 一种无血清制备牛支原体抗原的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5540568B2 (de) * 1972-10-05 1980-10-18
GB9108682D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Production of vaccines
WO1995022314A1 (en) * 1994-02-18 1995-08-24 Innovac Co. Inoculation of animals with dried, pelleted biological materials
US7943153B1 (en) * 1999-11-08 2011-05-17 Biomune Vaccines for Mycoplasma bovis and methods of use
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
WO2002089838A1 (en) 2002-11-14
MXPA03010053A (es) 2004-03-09
ATE335505T1 (de) 2006-09-15
US20040170652A1 (en) 2004-09-02
DK1387693T3 (da) 2006-11-13
EP1387693B1 (de) 2006-08-09
PT1387693E (pt) 2006-12-29
DE60213785T2 (de) 2007-08-23
ES2269672T3 (es) 2007-04-01
EP1387693A1 (de) 2004-02-11
CA2445997A1 (en) 2002-11-14
CY1107538T1 (el) 2013-03-13
GB0110851D0 (en) 2001-06-27

Similar Documents

Publication Publication Date Title
MY192183A (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
SA516371506B1 (ar) تركيبات مولدة للمناعة مشتملة على مولدات مضاد ساكاريد كبسولية متقارنة واستخداماتها
PH12017501898A1 (en) Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
BR112018007812A2 (pt) polissacarídeo capsular, processo para preparar um polissacarídeo capsular e para fabricar uma vacina, composição imunogênica, vacina, métodos para tratamento ou prevenção de uma infecção, para imunizar um hospedeiro humano e para induzir uma resposta imune, e, uso de uma composição imunogênica.
UY26783A1 (es) Antígenos de estreptococo.
MX2017009308A (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
DK1326633T3 (da) Sammensætning omfattende immunogene mikropartikler
MX2011010976A (es) Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion.
DK2054431T3 (da) Konformere af bakterielle adhæsiner
MX2020008454A (es) Composicion inmunogenica que comprende antigenos estafilococicos.
CL2022000774A1 (es) Vacunas para vhb y métodos de tratamiento de vhb
NZ591950A (en) Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
PH12021550484A1 (en) Immunological adjuvant and vaccine composition including sting agonist
CY1107538T1 (el) Εμβολιο μυκοπλασματος αδρανοποιημενο με σαπωνινη
PH12018502120A1 (en) Live attenuated alphavirus constructs and methods and uses thereof
BRPI0608310A2 (pt) uso de um poxvìrus modificado para a indução rápida de imunidade contra um poxvìrus ou outros agentes infecciosos
DE60135318D1 (de) Rekombinante bcg-impfstoffe gegen intrazelluläre pathogene und anwendungsverfahren
ATE487489T1 (de) Rekombinante intrazellulärepathogen-immunogene zusammensetzungen und anwendungsverfahren
MX2021015155A (es) Polisacaridos de ramnosa.
AR010568A1 (es) Polipeptido, composicion de vacuna, uso del polipeptido en la fabricacion de una composicion, y metodo para producir en un mamifero una respuestainmuno-protectora contra la infeccion de helicobacter pylori
MX2022001937A (es) Composicion inmunogenica.
UA132124U (uk) Вакцина проти лептоспірозу м'ясоїдних бівалентна
MX2022015860A (es) Inmunizacion bacteriana que utiliza una vacuna con nanoparticulas.
MY190074A (en) A monovalent vaccine formulation and a method for preparation thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC